182 related articles for article (PubMed ID: 37570723)
1. Profiling the Antidiabetic Potential of Compounds Identified from Fractionated Extracts of
Onikanni SA; Lawal B; Munyembaraga V; Bakare OS; Taher M; Khotib J; Susanti D; Oyinloye BE; Noriega L; Famuti A; Fadaka AO; Ajiboye BO
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570723
[TBL] [Abstract][Full Text] [Related]
2. Structural insight into the glucokinase-ligands interactions. Molecular docking study.
Ermakova E
Comput Biol Chem; 2016 Oct; 64():281-296. PubMed ID: 27522106
[TBL] [Abstract][Full Text] [Related]
3. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
4. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
[TBL] [Abstract][Full Text] [Related]
5. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER
Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804
[TBL] [Abstract][Full Text] [Related]
6. Development of antidiabetic drugs from benzamide derivatives as glucokinase activator: A computational approach.
Ali A
Saudi J Biol Sci; 2022 May; 29(5):3313-3325. PubMed ID: 35844378
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators.
Charaya N; Pandita D; Grewal AS; Lather V
Comput Biol Chem; 2018 Apr; 73():221-229. PubMed ID: 29518630
[TBL] [Abstract][Full Text] [Related]
9. Glucokinase activators for the potential treatment of type 2 diabetes.
Grimsby J; Berthel SJ; Sarabu R
Curr Top Med Chem; 2008; 8(17):1524-32. PubMed ID: 19075763
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and activity evaluation of GK/PPARγ dual-target-directed ligands as hypoglycemic agents.
Lu J; Lei L; Huan Y; Li Y; Zhang L; Shen Z; Hu W; Feng Z
ChemMedChem; 2014 May; 9(5):922-7. PubMed ID: 24737574
[TBL] [Abstract][Full Text] [Related]
11. N-pyridin-2-yl benzamide analogues as allosteric activators of glucokinase: Design, synthesis, in vitro, in silico and in vivo evaluation.
Grewal AS; Kharb R; Prasad DN; Dua JS; Lather V
Chem Biol Drug Des; 2019 Mar; 93(3):364-372. PubMed ID: 30369030
[TBL] [Abstract][Full Text] [Related]
12. Assessing the potential of glucokinase activators in diabetes therapy.
Matschinsky FM
Nat Rev Drug Discov; 2009 May; 8(5):399-416. PubMed ID: 19373249
[TBL] [Abstract][Full Text] [Related]
13. Ethnopharmacological perspectives of glucokinase activators in the treatment of diabetes mellitus.
Sharma S; Wadhwa K; Choudhary M; Budhwar V
Nat Prod Res; 2022 Jun; 36(11):2962-2976. PubMed ID: 34044681
[TBL] [Abstract][Full Text] [Related]
14. Ligand-based modeling followed by in vitro bioassay yielded new potent glucokinase activators.
Taha MO; Habash M; Hatmal MM; Abdelazeem AH; Qandil A
J Mol Graph Model; 2015 Mar; 56():91-102. PubMed ID: 25574766
[TBL] [Abstract][Full Text] [Related]
15. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents.
Agrawal R; Jain P; Dikshit SN
Comb Chem High Throughput Screen; 2012 Dec; 15(10):849-76. PubMed ID: 23140189
[TBL] [Abstract][Full Text] [Related]
16. Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus.
Pfefferkorn JA; Guzman-Perez A; Litchfield J; Aiello R; Treadway JL; Pettersen J; Minich ML; Filipski KJ; Jones CS; Tu M; Aspnes G; Risley H; Bian J; Stevens BD; Bourassa P; D'Aquila T; Baker L; Barucci N; Robertson AS; Bourbonais F; Derksen DR; Macdougall M; Cabrera O; Chen J; Lapworth AL; Landro JA; Zavadoski WJ; Atkinson K; Haddish-Berhane N; Tan B; Yao L; Kosa RE; Varma MV; Feng B; Duignan DB; El-Kattan A; Murdande S; Liu S; Ammirati M; Knafels J; Dasilva-Jardine P; Sweet L; Liras S; Rolph TP
J Med Chem; 2012 Feb; 55(3):1318-33. PubMed ID: 22196621
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry approaches for glucokinase activation to treat type 2 diabetes.
Pal M
Curr Med Chem; 2009; 16(29):3858-74. PubMed ID: 19747136
[TBL] [Abstract][Full Text] [Related]
18. Identification of some bioactive compounds from Trignonella foenumgraecum as possible inhibitors of PPARϒ for diabetes treatment through molecular docking studies, pharmacophore modelling and ADMET profiling: An in-silico study.
Okoh OS; Yakubu A; Adegboyega AE; Uti DE; Obeten UN; Agada SA; Oluwaloni F; Johnson GI; Mela LP; Asomadu RO; Iwaloye O; Johnson TO; Orji OU
PLoS One; 2023; 18(5):e0284210. PubMed ID: 37200359
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review on glucokinase activators: Promising agents for the treatment of Type 2 diabetes.
Thilagavathi R; Hosseini-Zare MS; Malini M; Selvam C
Chem Biol Drug Des; 2022 Feb; 99(2):247-263. PubMed ID: 34714587
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a potent glucokinase activator with a favorable liver and pancreas distribution pattern for the treatment of type 2 diabetes mellitus.
Fujieda H; Kogami M; Sakairi M; Kato N; Makino M; Takahashi N; Miyazawa T; Harada S; Yamashita T
Eur J Med Chem; 2018 Aug; 156():269-294. PubMed ID: 30006171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
